Translational Regulation of T Regulatory Cells

NIH RePORTER · NIH · R01 · $606,410 · view on reporter.nih.gov ↗

Abstract

Project Summary The goal of this work is to develop a fundamental understanding of the translational regulation of T regulatory cell (Treg) development, of which very little is known, which can inform the development of more effective therapeutic approaches to the regulation of Tregs in human cancer and autoimmune disease. Our research has provided important insights into the molecular regulation of selective mRNA translation in Treg development which we ultimately seek to capitalize on in generation of more effective immune-based therapies. This work is directed to understanding and then targeting the privileged translation of Treg fate determining mRNAs. The objective of our research is to determine the mechanism at the level of translational control which key Treg mRNAs promote Treg development and immune suppression functions.

Key facts

NIH application ID
10356140
Project number
5R01AI137067-05
Recipient
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Principal Investigator
Robert Jay Schneider
Activity code
R01
Funding institute
NIH
Fiscal year
2022
Award amount
$606,410
Award type
5
Project period
2018-03-01 → 2024-02-29